News

Long-term Treatment for Wet AMD Enters Phase 2 Trials

Neurotech Pharmaceuticals, Inc. has announced that they have enrolled the first patient in their multicenter Phase 2 clinical trial of NT-503 Encapsulated Cell Therapy (ECT) for the long-term treatment of wet macular degeneration (AMD). NT-503 is a unique vascular endothelial growth factor (VEGF) receptor protein continuously produced by Neurotech’s versatile ECT implant. “This landmark proof-of-concept [Read More]

New Book On Eye Nutrition Answers Common Questions

Leading nutrition expert Jeffrey Anshel, OD, FAAO, has just published a new book titled “What You Must Know about Food and Supplements for Optimal Vision Care.” It is a practical guide to diets, supplements and lifestyles for peak ocular health, with excellent information about how to integrate supplements with mainstream medical treatments whenever appropriate. Dr. [Read More]

Driving Still Possible For Some With Low Vision

Low vision doesn’t have to mean losing the privilege of driving a car. That’s the position of the International Academy of Low Vision Specialists (IALVS), an organization committed to helping people realize there is “life after vision loss.” As part of fulfilling that mission, IALVS provides information on Department of Motor Vehicle (DMV) vision requirements in all 50 states, [Read More]